手术视频
关于我们
联系我们
中心官网
泌尿系统常见疾病循证医学证据
首页
良性前列腺增生
泌尿系统感染
泌尿系统结石
前列腺炎
前列腺癌
膀胱肿瘤
肾癌
其他
首页
搜索结果
证据分类
良性前列腺增生
病因/危险因素证据
诊断证据
治疗及预后证据
预防证据
临床路径
临床实践指南
手术视频
调查问卷
泌尿系统感染
病因/危险因素证据
诊断证据
治疗及预后证据
预防证据
临床路径
临床实践指南
泌尿系统结石
病因/危险因素证据
诊断证据
治疗及预后证据
预防证据
临床路径
临床实践指南
前列腺炎
病因/危险因素证据
诊断证据
治疗及预后证据
预防证据
临床路径
临床实践指南
前列腺癌
病因/危险因素证据
诊断证据
治疗及预后证据
预防证据
临床路径
临床实践指南
膀胱肿瘤
病因/危险因素证据
诊断证据
治疗及预后证据
预防证据
临床路径
临床实践指南
肾癌
病因/危险因素证据
诊断证据
治疗及预后证据
预防证据
临床路径
临床实践指南
其他
病因/危险因素证据
诊断证据
治疗及预后证据
预防证据
临床路径
临床实践指南
搜索结果
按关键字
按标题
按关键词
按摘要
按作者
按期刊
共搜索到
8条
与
Neoplasm Metastasis
有关的结果
Is metabolic syndrome associated with high tumor grade and stage of bladder cancer: a systematic review and meta-analysis
2021 年 发布于
Biomedical Journal
12 卷 第 7 期
Feng D.
Song P.
Yang Y.
Wei W.
Li L.
Antineoplastic Combined Chemotherapy Protocols/*therapeutic use
Carcinoma
Transitional Cell/*drug therapy/pathology
Clinical Trials
Phase II as Topic
Clinical Trials
Phase III as Topic
Humans
Neoplasm Metastasis
Neoplasm Staging
Practice Guidelines as Topic
Randomized Controlled Trials as Topic
Urinary Bladder Neoplasms/*drug therapy/pathology
Immune checkpoint inhibitors
Platinum-based chemotherapy
Survival outcomes
Treatment guidelines
Urothelial carcinoma
funded this work. MK
PK
and SD are employees of Evidera.
文献简介
原文链接
Does Ureteral Stenting Increase the Risk of Metachronous Upper Tract Urothelial Carcinoma in Patients with Bladder Tumors? A Systematic Review and Meta-analysis COMMENT
2021 年 发布于
Indian J Urol
206 卷 第 6 期
Greco F.
Administration
Intravesical
Antineoplastic Agents/*administration & dosage/adverse effects
Clinical Trials as Topic
Disease Progression
Humans
Neoplasm Metastasis
*Neoplasm Recurrence
Local
Network Meta-Analysis
Progression-Free Survival
Risk Assessment
Risk Factors
Time Factors
Urinary Bladder Neoplasms/*drug therapy/mortality/pathology
文献简介
原文链接
Treatment Patterns in High-Risk, Bacille Calmette-Guerin Unresponsive Non-Muscle Invasive Bladder Cancer Patients: A Systematic Literature Review
2020 年 发布于
Cancer Manag Res
65 卷 第 5 期
Broughton E.
Chun D.
Gooden K.
Hofer K.
Fazeli M. S.
Abdominal Muscles/*physiopathology
Female
*Health Services Needs and Demand
Humans
Middle Aged
Neoplasm Metastasis
/*physiopathology
Quality of Life/*psychology
*Social Support
Urinary Bladder Neoplasms/*psychology/*secondary/therapy
Bladder cancer
Concerns
Continent diversion
Quality of life
Systematic review
Unmet supportive care needs
文献简介
原文链接
The impact of low muscle mass to overall survival in bladder cancer patients undergoing chemotherapy: A systematic review and meta-analysis
2020 年 发布于
Scand J Urol
18 卷 第 19 期
Japar K. V.
Kwenandar F.
Damay V.
Hariyanto T. I.
Kurniawan A.
Databases
Factual
Disease-Free Survival
Humans
Lymphocytes/*cytology/immunology
Neoplasm Metastasis
Neutrophils/*cytology/immunology
Odds Ratio
Prognosis
Proportional Hazards Models
Risk Assessment
Survival Rate
Urinary Bladder Neoplasms/immunology/mortality/*pathology
Urologic Neoplasms/immunology/mortality/*pathology
Bladder cancer
Metastatic unresectable urothelial carcinoma
Neutrophil-Lymphocyte ratio
Unresectable urothelial carcinoma
文献简介
原文链接
Association between coffee consumption and risk of bladder cancer in a meta-analysis of 16 prospective studies
2019 年 发布于
Onco Targets Ther
14 卷 第 19 期
Dai Z. W.
Cai K. D.
Li F. R.
Wu X. B.
Chen G. C.
Chemoradiotherapy/*methods
Combined Modality Therapy
Cystectomy/*adverse effects/methods
Disease-Free Survival
Female
Humans
Male
Middle Aged
Neoplasm Metastasis
Robotic Surgical Procedures/*adverse effects/methods
Treatment Outcome
Urinary Bladder Neoplasms/diagnostic imaging/*therapy
Bladder cancer
Cystectomy
Multi-modality treatment
Port-site metastasis
Rare complications
文献简介
原文链接
Prognostic Role of Platelet-to-Lymphocyte Ratio in Patients With Bladder Cancer: A Meta-Analysis
2019 年 发布于
Actas Urol Esp (Engl Ed)
98 卷 第 5 期
Wang X. M.
Ni X. Y.
Tang G. L.
Clinical Decision-Making
Cystectomy/*methods
Cytoreduction Surgical Procedures/methods
Humans
*
Neoplasm Metastasis
/pathology/therapy
Practice Guidelines as Topic
Treatment Outcome
*Urinary Bladder Neoplasms/pathology/surgery
Bladder cancer
Lymph node dissection
Lymph node metastasis
Metastasectomy
Metastatic bladder cancer
Surgery
interest
including specific financial interests and relationships and
affiliations relevant to the subject matter or materials discussed in the
manuscript (eg
employment/affiliation
grants or funding
consultancies
honoraria
stock ownership or options
expert testimony
royalties
or patents
filed
received
or pending)
are the following: None.
文献简介
原文链接
Is There an Association Between Ambient Air Pollution and Bladder Cancer Incidence? Analysis of 15 European Cohorts
2018 年 发布于
Diabetes Res Clin Pract
36 卷 第 9 期
Pedersen M.
Stafoggia M.
Weinmayr G.
Andersen Z. J.
Galassi C.
Sommar J.
Forsberg B.
Olsson D.
Oftedal B.
Krog N. H.
Aamodt G.
Pyko A.
Pershagen G.
Korek M.
De Faire U.
Pedersen N. L.
Östenson C. G.
Fratiglioni L.
Sørensen M.
Eriksen K. T.
Tjønneland A.
Peeters P. H.
Bueno-de-Mesquita B.
Vermeulen R.
Eeftens M.
Plusquin M.
Key T. J.
Jaensch A.
Nagel G.
Concin H.
Wang M.
Tsai M. Y.
Grioni S.
Marcon A.
Krogh V.
Ricceri F.
Sacerdote C.
Ranzi A.
Cesaroni G.
Forastiere F.
Tamayo I.
Amiano P.
Dorronsoro M.
Stayner L. T.
Kogevinas M.
Nieuwenhuijsen M. J.
Sokhi R.
de Hoogh K.
Beelen R.
Vineis P.
Brunekreef B.
Hoek G.
Raaschou-Nielsen O.
Adult
Aged
Aged
80 and over
Antibodies
Monoclonal/therapeutic use
Antibodies
Monoclonal
Humanized/therapeutic use
B7-H1 Antigen/*antagonists & inhibitors/genetics
CTLA-4 Antigen/*antagonists & inhibitors/genetics
Clinical Trials as Topic
Female
Genes
cdc/drug effects
Humans
Ipilimumab
Male
Middle Aged
Neoplasm Metastasis
/*drug therapy/genetics/pathology
Nivolumab
Urinary Bladder Neoplasms/*drug therapy/genetics/pathology
Bladder cancer immunotherapy
Checkpoint inhibitor
Pembrolizumab
文献简介
原文链接
对比在浸润性膀胱癌的治疗中保留膀胱综合治疗与根治性膀胱切除术 5 年生存率的 Meta 分析
2018 年 发布于
Bladder Cancer
32 卷 第 14 期
周毅恒
Kaplan-Meier Estimate
Neoplasm Grading
Neoplasm Metastasis
Neoplasm Staging
Odds Ratio
Prognosis
Publication Bias
Urinary Bladder Neoplasms/*mortality/*pathology/therapy
histological variants
squamous differentiation
urothelial carcinoma of the bladder
including specific financial interests and relationships and affiliations
relevant to the subject matter or materials discussed in the manuscript (eg
employment/affiliation
grants or funding
consultancies
honoraria
stock
ownership or options
expert testimony
royalties
or patents filed
received
or
pending)
are the following: None.
文献简介
原文链接